We are pleased to announce the next chapter of our exciting journey as a disruptive innovator in clinical diagnostics: Quotient is becoming AliveDx. AliveDx is more than a name, it is a call to action. AliveDx brings urgency to the work that we do as leaders in innovation and healthcare. When we become ‘alive,’ we do more than just live — we give energy, meaning, and purpose to our life. We believe faster diagnosis must be a top priority for clinical diagnostics. Developing innovative testing methods to reduce the time to diagnosis stops the long-term negative consequences for those living with autoimmune diseases. Faster disease detection prevents life-threatening health outcomes and brings peace of mind to patients. Not only must we support life, but help people to live better. Our mission is to empower diagnostic insights, transform patient care, and innovate for life. Our products, Alba and MosaiQ, have already demonstrated valuable contributions in the areas of transfusion and clinical diagnostics. We will continue to innovate and deliver more products for our customers as AliveDx. Join us as we come alive together in this next chapter and stay tuned for our full AliveDx brand launch this fall.
Quotient is becoming AliveDx
Trending Topics
Our passion for the work we do is matched only by our commitment to consistently provide the best customer experience possible.
-
AliveDx Announces Multiple Evaluation Sites of its MosaiQ® Solution
AliveDx is dedicated to expanding its reach and presence across diverse regions, with the goal of delivering both clinical and economical value to clinicians by reducing the time to diagnosis for patients suffering from autoimmune and allergy diseases. We are
-
Join us at the upcoming International Friday Meeting
We are delighted to speak at the upcoming International Friday Meeting on Friday, 6 December 2024 at 6:30AM CET. The International Friday Meeting is a monthly meeting, held on the first Friday of the month, hosted by Pr. Yehuda Shoenfeld.
-
AliveDx Suisse S.A. and Medikonia Limited Sign Distribution Agreement in Hong Kong and Macau
AliveDx Suisse S.A. and Medikonia Limited have signed a distribution agreement, which will enable Medikonia to distribute the MosaiQ® solution in Hong Kong and Macau. The distribution agreement takes effect immediately. AliveDx is committed to broadening its reach and presence
-
AliveDx Becomes a Member of BIVDA
We are proud to announce that we have become a member of BIVDA, the UK’s leading IVD industry association. BIVDA is the national industry association for manufacturers and distributors of medical diagnostic tests in the UK, representing 97% of the
-
AliveDx Suisse S.A. and Bio-State Inc. Sign Distribution Agreement in India
AliveDx Suisse S.A. and Bio-State Inc. have signed a distribution agreement, which will enable Bio-State Inc. to distribute the MosaiQ® solution in India. The distribution agreement takes effect immediately. This strategic partnership with an important partner in India reaffirms AliveDx’s
-
Join us at AABB 2024!
Meet the Alba team at the AABB Annual Meeting to learn how our high-quality blood bank reagents can drive value in your lab! Sign up for a booth meeting with your Account Executive today.
